05.08.13
Harlan Laboratories is expanding its specialty research production facilities in Indianapolis and Livermore, CA, doubling the number of isolators for its immunocompromized models.
The environmentally controlled breeding isolators are supported by individual air supply and HEPA filtered air handling to ensure the integrity of the colony within each isolator. The facilities also feature the latest equipment and biosecurity measures including a watering system with automatic flushing to help prevent the unwanted proliferation of organisms, as well as a backup power system.
“Our investment in these facilities underscores our commitment to providing the highest quality research models and services to investigators across the globe,” said Joe Meyer, vice president Global Commercial Operations at Harlan Laboratories. “We will continue to expand and enhance our facilities worldwide to meet the needs of the research community in key therapeutic research areas like oncology, immunology and toxicology with consistently dependable research models, diets and supporting services.”
The environmentally controlled breeding isolators are supported by individual air supply and HEPA filtered air handling to ensure the integrity of the colony within each isolator. The facilities also feature the latest equipment and biosecurity measures including a watering system with automatic flushing to help prevent the unwanted proliferation of organisms, as well as a backup power system.
“Our investment in these facilities underscores our commitment to providing the highest quality research models and services to investigators across the globe,” said Joe Meyer, vice president Global Commercial Operations at Harlan Laboratories. “We will continue to expand and enhance our facilities worldwide to meet the needs of the research community in key therapeutic research areas like oncology, immunology and toxicology with consistently dependable research models, diets and supporting services.”